
Investing.com – Israel stocks were higher after the close on Monday, as gains in the Insurance, Oil&Gas and Financials sectors led shares higher.
At the close in Tel Aviv, the TA 35 rose 0.15%.
The best performers of the session on the TA 35 were Phoenix Holdings Ltd (TASE:PHOE1), which rose 2.79% or 103.00 points to trade at 3,801.00 at the close. Meanwhile, ICL Israel Chemicals Ltd (TASE:ICL) added 2.47% or 63.00 points to end at 2,613.00 and Harel (TASE:HARL) was up 2.33% or 72.00 points to 3,157.00 in late trade.
The worst performers of the session were OPKO Health Inc (TASE:OPK), which fell 4.98% or 21.40 points to trade at 409.00 at the close. Strauss Group (TASE:STRS) declined 1.64% or 150.00 points to end at 9,000.00 and Nova (TASE:NVMI) was down 1.36% or 400.00 points to 29,060.00.
Rising stocks outnumbered declining ones on the Tel Aviv Stock Exchange by 253 to 215 and 41 ended unchanged.
Shares in OPKO Health Inc (TASE:OPK) fell to all time lows; losing 4.98% or 21.40 to 409.00.
Crude oil for February delivery was up 2.34% or 1.74 to $76.20 a barrel. Elsewhere in commodities trading, Brent oil for delivery in February rose 1.85% or 1.46 to hit $80.50 a barrel, while the February Gold Futures contract fell 0.12% or 2.15 to trade at $1,798.05 a troy ounce.
USD/ILS was unchanged 0.13% to 3.45, while EUR/ILS rose 0.18% to 3.67.
The US Dollar Index Futures was down 0.18% at 104.14.
Begin trading today! Create an account by completing our form
At One Financial Markets we are committed to safeguarding your privacy.
Please see our Privacy Policy for details about what information is collected from you and why it is collected. We do not sell your information or use it other than as described in the Policy.
Please note that it is in our legitimate business interest to send you certain marketing emails from time to time. However, if you would prefer not to receive these you can opt-out by ticking the box below.
Alternatively, you can use the unsubscribe link at the bottom of the Demo account confirmation email or any subsequent emails we send.
By completing the form and downloading the platform you agree with the use of your personal information as detailed in the Policy.